Novo Nordisk A/S (NVO)
NYSE: NVO · IEX Real-Time Price · USD
124.51
-0.89 (-0.71%)
At close: Apr 12, 2024, 4:00 PM
124.36
-0.15 (-0.12%)
After-hours: Apr 12, 2024, 7:59 PM EDT

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of $555.41 billion. The enterprise value is $554.96 billion.

Market Cap 555.41B
Enterprise Value 554.96B

Important Dates

The next estimated earnings date is Thursday, May 2, 2024, before market open.

Earnings Date May 2, 2024
Ex-Dividend Date Mar 22, 2024

Share Statistics

Novo Nordisk has 4.46 billion shares outstanding.

Shares Outstanding 4.46B
Owned by Insiders (%) 0.00%
Owned by Institutions (%) 9.28%
Float 3.19B

Valuation Ratios

The trailing PE ratio is 46.46 and the forward PE ratio is 37.59. Novo Nordisk's PEG ratio is 2.40.

PE Ratio 46.46
Forward PE 37.59
PS Ratio 16.76
Forward PS 1.94
PB Ratio 36.54
P/FCF Ratio 55.61
PEG Ratio 2.40
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 33.67, with an EV/FCF ratio of 55.57.

EV / Earnings 46.49
EV / Sales 16.75
EV / EBITDA 33.67
EV / EBIT 36.65
EV / FCF 55.57

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.25.

Current Ratio 0.82
Quick Ratio 0.62
Debt / Equity 0.25
Debt / EBITDA 0.23
Debt / FCF 0.39
Interest Coverage -201.41

Financial Efficiency

Return on equity (ROE) is 78.53% and return on invested capital (ROIC) is 61.40%.

Return on Equity (ROE) 78.53%
Return on Assets (ROA) 26.61%
Return on Capital (ROIC) 61.40%
Revenue Per Employee $515,118
Profits Per Employee $185,596
Employee Count 64,319
Asset Turnover 0.81
Inventory Turnover 1.27

Taxes

In the past 12 months, Novo Nordisk has paid $2.99 billion in taxes.

Income Tax 2.99B
Effective Tax Rate 20.05%

Stock Price Statistics

The stock price has increased by +52.29% in the last 52 weeks. The beta is 0.20, so Novo Nordisk's price volatility has been lower than the market average.

Beta (1Y) 0.20
52-Week Price Change +52.29%
50-Day Moving Average 125.48
200-Day Moving Average 102.69
Relative Strength Index (RSI) 44.65
Average Volume (30 Days) 5,102,606

Short Selling Information

Short Interest 2.83M
Short Previous Month 4.88M
Short % of Shares Out 0.14%
Short % of Float n/a
Short Ratio (days to cover) 0.50

Income Statement

In the last 12 months, Novo Nordisk had revenue of $33.13 billion and earned $11.94 billion in profits. Earnings per share was $2.66.

Revenue 33.13B
Gross Profit 28.03B
Operating Income 14.63B
Pretax Income 14.93B
Net Income 11.94B
EBITDA 16.48B
EBIT 15.14B
Earnings Per Share (EPS) $2.66
Full Income Statement

Balance Sheet

The company has $4.31 billion in cash and $3.85 billion in debt, giving a net cash position of $459.90 million or $0.10 per share.

Cash & Cash Equivalents 4.31B
Total Debt 3.85B
Net Cash 459.90M
Net Cash Per Share $0.10
Equity / Book Value 15.20B
Book Value Per Share 3.41
Working Capital -4.28B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $15.54 billion and capital expenditures -$5.55 billion, giving a free cash flow of $9.99 billion.

Operating Cash Flow 15.54B
Capital Expenditures -5.55B
Free Cash Flow 9.99B
FCF Per Share $2.23
Full Cash Flow Statement

Margins

Gross margin is 84.60%, with operating and profit margins of 44.16% and 36.03%.

Gross Margin 84.60%
Operating Margin 44.16%
Pretax Margin 45.07%
Profit Margin 36.03%
EBITDA Margin 49.75%
EBIT Margin 45.70%
FCF Margin 30.14%

Dividends & Yields

This stock pays an annual dividend of $0.82, which amounts to a dividend yield of 0.66%.

Dividend Per Share $0.82
Dividend Yield 0.66%
Dividend Growth (YoY) 161.52%
Years of Dividend Growth 4
Payout Ratio 30.59%
Buyback Yield 1.00%
Shareholder Yield 1.66%
Earnings Yield 2.15%
FCF Yield 1.80%
Dividend Details

Analyst Forecast

The average price target for Novo Nordisk is $133.00, which is 6.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target $133.00
Price Target Difference 6.82%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 13.54%
EPS Growth Forecast (5Y) 14.23%
Stock Forecasts

Stock Splits

The last stock split was on September 20, 2023. It was a forward split with a ratio of 2:1.

Last Split Date Sep 20, 2023
Split Type Forward
Split Ratio 2:1

Scores

Novo Nordisk has an Altman Z-Score of 13.44 and a Piotroski F-Score of 8.

Altman Z-Score 13.44
Piotroski F-Score 8